Press Releases

NEW YORK, Oct. 17, 2019 /PRNewswire/ -- AMC Health, a leader in virtual healthcare delivery solutions, is pleased to announce the launch of its newly redesigned website at

DENVER, Oct. 17, 2019 /PRNewswire/ -- SCB Global Healthcare Services, LLC, a Denver based healthcare services holding company founded by Warren Olsen and Russ Matthews, today announced that it has appointed Doug Weiss as President and Chief Custom

MINNEAPOLIS, Oct. 17, 2019 /PRNewswire/ -- Today, Bright Health announced it will begin offering individual and family plans to North Carolina residents in the Charlotte and Winston-Salem metro areas in 2020. Bright Health partnered with Novant Health, a leading heal

BOULDER, Colo., Oct. 17, 2019 /PRNewswire/ -- CannaInsider today announces the CBD Transparency Badge Program (

SOMERSET, United Kingdom, Oct. 17, 2019 /PRNewswire/ -- Living DNA (http://www.livingdna.com), the global direct-to-consumer genealogy DNA service that does not sell or share custo

NEW YORK, Oct. 17, 2019 /PRNewswire/ -- The US Navy Veterans Mesothelioma Advocate says, "We are the top branded source in the nation for US Navy Veterans with mesothelioma receiving the very best possible financial compensation results and not what we like to call trick or treat. Many to most US Navy Veterans with mesothelioma will never get properly compensated because

CAMBRIDGE, Mass., Oct. 17, 2019 /PRNewswire/ -- NED Biosystems, a clinical-stage biotech company investigating solutions for a broad range of cancers, is pleased to announce Brian Leyland-Jones, BS, MBBS, PhD, FRACP, FRCPC, has been named Chairman of the Scientific Advisory Board. Dr. Leyland-Jones is a pre-eminent expert in cancer therapy,

PHILADELPHIA, Oct. 17, 2019 /PRNewswire/ -- NetDiligence®, a leading provider of cyber risk readiness and response services, has announced that Adam Abresch of Acrisure has been awarded the 2019 Toby Merrill Rising Star Award. The award was presented on October 16, 2019 at the company's Cyber Ris

NEW YORK, Oct. 17, 2019 /PRNewswire/ -- Relmada Therapeutics Inc. (NASDAQ: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system diseases, announced today that the Relmada team will ring the NASDAQ stock market opening bell tomorrow, Friday, October 18, 2019, at 9:30 AM

TORONTO, Oct. 17, 2019 /PRNewswire/ -- Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) today announced the presentation of data from the NATESTO® Spermatogenesis Study as part of the "Late Breaking" Abstract Session at the 75th Annual American Society for Reproductive Medicine (ASRM) Scientific Conference in